Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
Abstract
treatment
Anem Waheed, MD, MPH
Waheed, Anem
Assistant Professor of Medicine
Weill Cornell Medicine
Online Profile:
Never Give Up Hope
Person's Name:
Jane Biehl, PhD
I am thrilled because I have already written two articles for AAMDS and am now writing a third one at their request. I am so grateful to still be well enough to do this.
The first article, written in 2017, talked about my initial diagnosis in 2010 of MDS del5Q. MDS is separated into 5 categories and typically patients live the longest with this extremely rare type.
Bone Marrow Disease(s):
Content source:
MPN Non-Transplant Therapies - From the 2024 Seattle Patient and Family Conference
Dr. Anna Halpern describes treatment options for Myeloproliferative Neoplasms for patients who will not be treated by a bone marrow transplant. This recording is a session from the 2024 Seattle Patient and Family Conference, ready for on-demand viewing.
MPN (Myeloproliferative Neoplasms) and Transplant Therapies - From the 2024 Seattle Patient/Family Conference
Dr. Rachel Salit explains the condition, Myeloproliferative Neoplasms, along with treatment options. Her session focuses on bone marrow transplantation as a treatment for this rare disease.
MDS and Transplant Therapies - From the 2024 Seattle Patient and Family Conference
When is a bone marrow transplant offered as a treatment for MDS? Which patients are most eligible, and what are possible drawbacks? Watch this session, presented by Dr. Naveed Ali, from the 2024 Seattle Patient and Family Conference to find the answers, and much more.